Canada Life
IRD

Canada Life’s Opus Genetics IRD Stock Holding History

Canada Life’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17
Closed -$5K – 2600
2015
Q2 		$5K Hold
17
– – ﹤0.01% 2583
2015
Q1 		$6K Hold
17
– – ﹤0.01% 2477
2014
Q4 		$6K Hold
17
– – ﹤0.01% 2465
2014
Q3 		$5K Hold
17
– – ﹤0.01% 2453
2014
Q2 		$8K Buy
17
+11
+183% +$5K ﹤0.01% 2332
2014
Q1 		$4K Hold
6
– – ﹤0.01% 2251
2013
Q4 		$1K Hold
6
– – ﹤0.01% 2267
2013
Q3 		$1K Buy
+6
New +$1.4K ﹤0.01% 1161

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Canada Life's IRD Position: Q3 2015 in Review

Canada Life sold out of Opus Genetics (IRD) in Q3 2015, closing a stake of 17 shares — an estimated $5K sold.

Canada Life first reported a position in IRD in Q3 2013 and held it in 8 quarters. The position peaked at $8K in Q2 2014. 31 funds tracked by Wall St. Rank hold IRD as of Q3 2015.

  • Canada Life reported no remaining Opus Genetics position as of Q3 2015 after selling out during the quarter.
  • Canada Life sold 17 Opus Genetics shares in Q3 2015, an estimated $5K.
  • Canada Life first reported a position in Opus Genetics in Q3 2013 and held it in 8 quarters.
  • Canada Life's Opus Genetics position peaked at $8K in Q2 2014.
  • 31 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2015.

Based on Canada Life's 13F filing for Q3 2015, filed 10 Nov 2015.